94885-02-6,MFCD00467024
Catalog No.:AA01CBLF

94885-02-6 | Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$255.00   $178.00
- +
5mg
≥98%
in stock  
$1,133.00   $793.00
- +
10mg
≥98%
in stock  
$2,010.00   $1,407.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01CBLF
Chemical Name:
Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
CAS Number:
94885-02-6
Molecular Formula:
C30H49N5O6
Molecular Weight:
575.7400
MDL Number:
MFCD00467024
SMILES:
CCCCCCCCCCCCC/C=C/[C@H]([C@@H](NC(=O)CCCCCNc1ccc(c2c1non2)[N+](=O)[O-])CO)O
Properties
Computed Properties
 
Complexity:
737  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
41  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0  
Rotatable Bond Count:
23  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
7.3  

Literature

Title: A novel pathway of ceramide metabolism in Saccharomyces cerevisiae.

Journal: The Biochemical journal 20121001

Title: Labeling Golgi with fluorescent ceramides.

Journal: Cold Spring Harbor protocols 20120801

Title: ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110601

Title: Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.

Journal: Journal of lipid research 20100401

Title: Clonal isolation of chlamydia-infected cells using flow cytometry.

Journal: Journal of microbiological methods 20070101

Title: Disruption of the plasma membrane stimulates rearrangement of microtubules and lipid traffic toward the wound site.

Journal: Journal of cell science 20060701

Title: D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.

Journal: Biochemistry 20060411

Title: Sterol carrier protein-2 expression alters sphingolipid metabolism in transfected mouse L-cell fibroblasts.

Journal: Molecular and cellular biochemistry 20060201

Title: Effect of membrane perturbants on the activity and phase distribution of inositol phosphorylceramide synthase; development of a novel assay.

Journal: Biochemistry 20040706

Title: Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes.

Journal: The Journal of biological chemistry 20040102

Title: Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: implications for the regulation of apoptosis.

Journal: The Journal of biological chemistry 20030718

Title: Trans-Golgi network and subapical compartment of HepG2 cells display different properties in sorting and exiting of sphingolipids.

Journal: The Journal of biological chemistry 20030103

Title: High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates.

Journal: Journal of lipid research 20020501

Title: Enhancement of diphtheria toxin-induced apoptosis in Vero cells by combination treatment with brefeldin A and okadaic acid.

Journal: Cell structure and function 20011001

Title: Uptake and hydrolysis of sphingomyelin analogues in Plasmodium falciparum-infected red cells.

Journal: Molecular and biochemical parasitology 20010701

Title: Peptide-based targeting of fluorophores to organelles in living cells.

Journal: Experimental cell research 20010501

Title: Fluorescent staining of subcellular organelles: ER, Golgi complex, and mitochondria.

Journal: Current protocols in cell biology 20010501

Title: Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.

Journal: Brain research 20010323

Title: Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells.

Journal: Cellular microbiology 20010301

Title: Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells.

Journal: The Journal of biological chemistry 19981120

Title: Lipsky NG, et al. A vital stain for the Golgi apparatus. Science. 1985 May 10;228(4700):745-7.

Title: Brandán YR, et al. Influence of sphingomyelin metabolism during epithelial-mesenchymal transition associated with aging in the renal papilla. J Cell Physiol. 2022 Jul 31.

Title: Pagano RE. A fluorescent derivative of ceramide: physical properties and use in studying the Golgi apparatus of animal cells. Methods Cell Biol. 1989;29:75-85.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 94885-02-6
Tags:94885-02-6 Molecular Formula|94885-02-6 MDL|94885-02-6 SMILES|94885-02-6 Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
Catalog No.: AA01CBLF
94885-02-6,MFCD00467024
94885-02-6 | Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
Pack Size: 1mg
Purity: ≥98%
in stock
$255.00 $178.00
Pack Size: 5mg
Purity: ≥98%
in stock
$1,133.00 $793.00
Pack Size: 10mg
Purity: ≥98%
in stock
$2,010.00 $1,407.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01CBLF
Chemical Name: Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
CAS Number: 94885-02-6
Molecular Formula: C30H49N5O6
Molecular Weight: 575.7400
MDL Number: MFCD00467024
SMILES: CCCCCCCCCCCCC/C=C/[C@H]([C@@H](NC(=O)CCCCCNc1ccc(c2c1non2)[N+](=O)[O-])CO)O
Properties
Complexity: 737  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 41  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 4  
Isotope Atom Count: 0  
Rotatable Bond Count: 23  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 7.3  
Literature fold

Title: A novel pathway of ceramide metabolism in Saccharomyces cerevisiae.

Journal: The Biochemical journal20121001

Title: Labeling Golgi with fluorescent ceramides.

Journal: Cold Spring Harbor protocols20120801

Title: ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20110601

Title: Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.

Journal: Journal of lipid research20100401

Title: Clonal isolation of chlamydia-infected cells using flow cytometry.

Journal: Journal of microbiological methods20070101

Title: Disruption of the plasma membrane stimulates rearrangement of microtubules and lipid traffic toward the wound site.

Journal: Journal of cell science20060701

Title: D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.

Journal: Biochemistry20060411

Title: Sterol carrier protein-2 expression alters sphingolipid metabolism in transfected mouse L-cell fibroblasts.

Journal: Molecular and cellular biochemistry20060201

Title: Effect of membrane perturbants on the activity and phase distribution of inositol phosphorylceramide synthase; development of a novel assay.

Journal: Biochemistry20040706

Title: Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes.

Journal: The Journal of biological chemistry20040102

Title: Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: implications for the regulation of apoptosis.

Journal: The Journal of biological chemistry20030718

Title: Trans-Golgi network and subapical compartment of HepG2 cells display different properties in sorting and exiting of sphingolipids.

Journal: The Journal of biological chemistry20030103

Title: High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates.

Journal: Journal of lipid research20020501

Title: Enhancement of diphtheria toxin-induced apoptosis in Vero cells by combination treatment with brefeldin A and okadaic acid.

Journal: Cell structure and function20011001

Title: Uptake and hydrolysis of sphingomyelin analogues in Plasmodium falciparum-infected red cells.

Journal: Molecular and biochemical parasitology20010701

Title: Peptide-based targeting of fluorophores to organelles in living cells.

Journal: Experimental cell research20010501

Title: Fluorescent staining of subcellular organelles: ER, Golgi complex, and mitochondria.

Journal: Current protocols in cell biology20010501

Title: Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.

Journal: Brain research20010323

Title: Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells.

Journal: Cellular microbiology20010301

Title: Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells.

Journal: The Journal of biological chemistry19981120

Title: Lipsky NG, et al. A vital stain for the Golgi apparatus. Science. 1985 May 10;228(4700):745-7.

Title: Brandán YR, et al. Influence of sphingomyelin metabolism during epithelial-mesenchymal transition associated with aging in the renal papilla. J Cell Physiol. 2022 Jul 31.

Title: Pagano RE. A fluorescent derivative of ceramide: physical properties and use in studying the Golgi apparatus of animal cells. Methods Cell Biol. 1989;29:75-85.

Building Blocks More >
86383-32-6
86383-32-6
1-Propanone,1-[5-hydroxy-2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-,hydrochloride
AA01CBP0 | MFCD08063695
94820-65-2
94820-65-2
2H-1-Benzopyran-2-one, 4,7-dihydroxy-3-[3-oxo-1-(phenyl-d5)butyl]-
AA01CBRM | MFCD00272675
1217831-76-9
1217831-76-9
Iopamidol-d3
AA01CBUO | MFCD29036873
1356837-87-0
1356837-87-0
Penicillin V-d5
AA01CBY6 | MFCD09952267
51582-41-3
51582-41-3
Oxirane, [3-nitro-4-(phenylmethoxy)phenyl]-
AA01CC1F | MFCD07782084
132331-92-1
132331-92-1
Maltol-d3
AA01CC4G
947723-87-7
947723-87-7
(αZ)-α-(Methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetamide
AA01CC7X | MFCD29045157
1132661-86-9
1132661-86-9
Ramipril-d5
AA01CCB8
1219386-75-0
1219386-75-0
D,L Carnitine-d9 Chloride
AA01CCEO | MFCD03428232
960226-55-5
960226-55-5
Tadalafil-d3
AA01CCHT | MFCD04116200
Submit
© 2017 AA BLOCKS, INC. All rights reserved.